L. Llaó Cid

EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia

D. Colomer, P. Lichter, Fabian Kilpert, 2021, Leukemia.

Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

M. Saleh, M. Seiffert, P. Roessner, 2021, Frontiers in Immunology.

T cell landscape definition by multi-omics identifies Galectin-9 as novel immunotherapy target in chronic lymphocytic leukemia

A. Rosenwald, D. Colomer, P. Lichter, 2022, bioRxiv.

CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion

P. Lichter, M. Iskar, M. Zapatka, 2020, Leukemia & lymphoma.

TBET‐expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ‐TCL1 mice

D. Colomer, P. Lichter, S. Stilgenbauer, 2019, British journal of haematology.

High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target

A. Rosenwald, D. Colomer, P. Lichter, 2023, bioRxiv.